compounds

PPD and Janssen Pharmaceutica to Develop Therapeutic Compounds

PPD has entered an agreement with Janssen Pharmaceutica to develop and commercialize two Phase II-ready therapeutic compounds – one to treat diarrhea-predominant irritable bowel syndrome (IBS-d) and the other to treat complicated skin and skin stru…

compounds | 11 January 2010

• PPD
• Janssen
• Pharmaceutica
• therapeutic

Determining Compound Solubility

The SFT Phase Monitor II from Supercritical Fluid Technologies, is an analytical tool for determining the solubility of various compounds and mixtures of compounds in subcritical and supercritical fluids. It provides direct, visual observation of mat…

compounds | 29 September 2009

• SFT
• Phase
• Monitor
• Supercritical
• Fluid
• solubility
• compounds
• subcritical

Powder distribution and weighing system for library compounds

Zinsser Analytic’s CALLI-L is an automatic platform with a robotic arm supplied with a powder dispensing probe and a handler for transportation of vials. The system is designed for the distribution of dry, powder library samples for dissolution…

compounds | 27 November 2008

• Powder
• distribution
• weighing
• library
• compounds
• Zinsser
• Analytic

AstraZeneca Partners Singapore Institutions to Develop Anti-Cancer Compounds

AstraZeneca has signed a memorandum of understanding (MOU) with the National Cancer Centre Singapore (NCCS) and the National University Hospital (NUH) to develop anti-cancer compounds. The collaboration aims to strengthen Astra- Zeneca’s drug de…

compounds | 01 September 2008

• AstraZeneca
• MOU
• National
• Cancer
• Centre
• Singapore
• University

Tikvah Therapeutics, Chakra Biotech To Accelerate The Development Of Novel Antipsychotic Compounds

Tikvah Therapeutics, Inc., and Chakra Biotech PL, has announced a collaboration and option agreement designed to advance and accelerate the development of four compounds targeted at a broad range of psychiatric conditions, including schizophrenia and…

compounds | 24 September 2007

Bridgetech Gains Asian Rights to Two Cancer Compounds

San Diego-based Bridgetech Holdings International Inc., has acquired the Asian rights to two reformulated cancer therapeutics. The company will manufacture and distribute them to China, Hong Kong, Macau, and Taiwan. It has also gained the rights t…

compounds | 01 June 2006